Related Experiment Videos
[New treatments for idiopathic juvenile arthritis]
1Service d'Immunologie, d'Hématologie et de Rhumatologie Pédiatriques, Centre de Référence << Arthrites Juvéniles >>, Université Paris Descartes, Hôpital Necker-Enfants-Malades, 149 Rue de Sèvres, 75015 Paris, France. brigitte.bader-meunier@nck.aphp.fr
Abstract:
Immunosuppressants, including methotrexate and more recently anti-TNF alpha, anti-IL1 and anti-IL6 receptor, have modified the prognosis of juvenile idiopathic arthritis. Growth hormone was shown to limit growth retardation due to general corticotherapy.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Rheumatic Heart Disease III: Medical Management
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...